Clinical Trial

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
This goal of this study is to assess the safety and immunogenicity of recombinant zoster virus in young adult solid organ transplant recipients. In this study, participants will receive the recombinant zoster vaccine. They will be monitored for adverse events and tested for antibody and cellular immunity.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-27; most recent amendment 2026-03-24.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-12-10
Trial Details
NCT Number NCT06162494
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators: Children's Hospital Colorado, Children's Hospital Medical Center, Cincinnati
Conditions Varicella Zoster
Enrollment 80 participants
Start Date 2024-03-18
Primary Completion 2027-03-31 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-27